650 filings
Page 5 of 33
8-K
832ihs6j
11 Mar 21
Achieve Reports Financial Results for Fourth Quarter and Year-End 2020 and Provides Corporate Update
4:08pm
424B4
h3lcukooe231eq
4 Dec 20
Prospectus supplement with pricing info
12:00am
EFFECT
4jzmk09 oo5fiw
3 Dec 20
Notice of effectiveness
12:15am
S-1MEF
fg5rkpm4lpkgd k59
2 Dec 20
Registration of additional securities for an S-1
8:57pm
FWP
7iazry9tqt8bpja
30 Nov 20
Free writing prospectus
7:08am
CORRESP
g2bxjnundq
30 Nov 20
Correspondence with SEC
12:00am
UPLOAD
81dqlf89e
18 Nov 20
Letter from SEC
12:00am
8-K
8e2ab9q753tcl9d7xq
12 Nov 20
Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
4:08pm
8-K
9k4 vitvy
22 Oct 20
Regulation FD Disclosure
9:11am
8-K
f8trxx2kj0xws yz78
21 Oct 20
Termination of a Material Definitive Agreement
9:01am
8-K
hhswiiv6xxed
30 Sep 20
Departure of Directors or Certain Officers
8:10am
8-K
y6bko 3cb7k9pw
20 Aug 20
Other Events
4:05pm
8-K
3or1qi
6 Aug 20
Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program
4:11pm
424B5
8af0ntzrw a53xv3xu
5 Aug 20
Prospectus supplement for primary offering
12:00am
8-K
gw1dng38l837ln n1
5 Aug 20
Entry into a Material Definitive Agreement
12:00am
424B5
995 9mrrqh
3 Aug 20
Prospectus supplement for primary offering
4:07pm